![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Open AccessValvular dysfunction and left ventricular changes in Hodgkin's lymphoma survivors. A longitudinal study
Hodgkin's lymphoma survivors (HLSs) have an elevated risk for cardiovascular diseases that appear several years after radiotherapy. This study examined the time-dependent development and evolution of valvular ...
-
Article
Treatment-related differences in cardiovascular risk factors in long-term survivors of testicular cancer
Treatment in testicular cancer survivors (TCSs) may be followed by cardiovascular disorders. We have examined whether today’s three treatment modalities are assicated with a biochemical cardiovascular risk pro...
-
Article
Heart failure and statins—Why do we need a clinical trial?
Der Effekt einer Therapie mit Statinen auf die Morbidität und Sterblichkeit ist bei Patienten in der Sekundärund Primärprävention sowie bei Patienten mit akutem Koronarsyndrom gut belegt. Neuere Untersuchungen...
-
Chapter
Herzfrequenzreduktion — ein wichtiger Mechanismus für eine günstige Beeinflussung der Prognose
Die Herzfrequenz ist ein prognostischer Index des kardiovaskulären Risikos vor, während und nach einem koronaren Ereignis [1,2,3]. Nach einem akuten Myokardinfarkt beträgt das Risikoverhältnis fär Patienten mi...
-
Article
Discussion
-
Article
Effect of ACE-inhibition on tissue blood flow during acute left ventricular failure in the dog
Anesthetized dogs in acute left ventricular failure were treated with the ACE-inhibitor enalaprilat (MK-422). ACE-inhibition produced a fall in the mean blood pressure and a redistribution of cardiac output to...
-
Chapter
Cardiovascular Responses to Combined Apnoea and Face Immersion in Exercising Man
When a seal dives, a striking redistribution of the blood supply occurs in order to conserve the total oxygen stores for the tissues that need it most — particularly the brain. The most prominent feature of th...
-
Article
Effect of penbutolol (Hoe 893 d) and practolol on exercise-induced angina pectoris 2 and 24 hours after a single oral dose
The effect of penbutolol (Hoe 893 d), a new non-cardioselective beta-blocking agent presumed to have a prolonged action, was compared with practolol and placebo by exercise tests in 12 male patients with stabl...